Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
81.37 USD | +0.96% | -1.12% | -1.23% |
May. 30 | Daiwa Securities Adjusts Price Target on Medtronic to $92 From $100 | MT |
May. 29 | Medtronic Prices 3 Billion Euros Senior Notes Offering | MT |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm trades with high earnings multiples: 23.2 times its 2024 earnings per share.
- With an enterprise value anticipated at 4 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.23% | 107B | C | ||
-7.16% | 178B | C+ | ||
-4.86% | 67.04B | A | ||
-4.28% | 47.23B | B- | ||
+10.32% | 44.62B | B- | ||
+8.14% | 42.5B | B+ | ||
+15.76% | 29.99B | B | ||
+15.53% | 25.22B | A- | ||
-5.88% | 24.14B | A- | ||
-5.38% | 23.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MDT Stock
- Ratings Medtronic plc